Fallopian Tube Cancer
📧 Sign up to get email alerts when something new happens for Fallopian Tube Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-12-14Clinical Trial Update: Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer [Phase 3]
This Phase 3 trial evaluates whether adding bevacizumab to a carboplatin, paclitaxel, and gemcitabine regimen after surgery improves outcome…
-
CLINICAL_TRIALS trial_result · 2020-12-08Clinical Trial Update: A Study of Oral Rucaparib in Patients With a Solid Tumor (Phase I) or With gBRCA Mutation Ovarian Cancer (Phase II) [Phase 1, Phase 2]
Phase I/II study of oral rucaparib in patients with BRCA-mutant ovarian cancer and to a lesser extent solid tumors; study completed with res…
-
CLINICAL_TRIALS trial_result · 2020-11-12Clinical Trial Update: Anti-PD-L1 and SAbR for Ovarian Cancer [Phase 2]
Phase 2 trial of anti-PD-L1 therapy with SAbR (stereotactic ablative radiotherapy) in recurrent epithelial ovarian/fallopian tube/primary pe…
-
CLINICAL_TRIALS trial_result · 2020-11-10Clinical Trial Update: Trial of Trientine Plus Pegylated Liposomal Doxorubicin and Carboplatin in Epithelial Ovarian Cancer [Phase 1, Phase 2]
Phase 1/2 trial evaluating trientine plus pegylated liposomal doxorubicin and carboplatin in epithelial ovarian cancer and peritoneal/ fallo…
-
CLINICAL_TRIALS trial_result · 2020-10-22Clinical Trial Update: PankoMab-GEX™ Versus Placebo as Maintenance Therapy in Advanced Ovarian Cancer [Phase 2]
A Phase 2 trial comparing PankoMab-GEX as maintenance therapy to placebo in advanced ovarian cancer has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-09-14Clinical Trial Update: Veliparib With Carboplatin and Paclitaxel and as Continuation Maintenance Therapy in Adults With Newly Diagnosed Stage III or IV, High-grade Serous, Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 3]
A Phase 3 trial evaluating veliparib with carboplatin/paclitaxel and continuation maintenance in newly diagnosed stage III/IV high-grade ser…
-
CLINICAL_TRIALS trial_result · 2020-09-11Clinical Trial Update: Nivolumab With or Without Ipilimumab in Treating Patients With Persistent or Recurrent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer [Phase 2]
Phase 2 trial update reporting results for nivolumab with or without ipilimumab in patients with persistent or recurrent ovarian, fallopian …
-
CLINICAL_TRIALS trial_result · 2020-08-27Clinical Trial Update: Stratified Evaluation of PDS and NACT-IDS in Ovarian Cancer (FOCUS) [Phase 3]
Phase 3 trial investigating stratified evaluation of PDS and NACT-IDS in ovarian cancer is not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2020-08-11Clinical Trial Update: Japan Phase 2 Study of Niraparib in Participants With Advanced, Relapsed Ovarian Cancer [Phase 2]
Takeda-sponsored Phase 2 trial of Niraparib in advanced, relapsed ovarian cancer (including fallopian tube and primary peritoneal cancers) h…
-
CLINICAL_TRIALS trial_result · 2020-08-10Clinical Trial Update: Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed, Persistent or Recurrent Uterine, Ovarian, Fallopian Tube, or Peritoneal Cavity Cancer [Phase 3]
Phase 3 trial evaluating paclitaxel and carboplatin versus ifosfamide in newly diagnosed, persistent, or recurrent uterine, ovarian, fallopi…
-
CLINICAL_TRIALS trial_result · 2020-07-22Clinical Trial Update: Cediranib Maleate and Olaparib in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Peritoneal Cancer or Recurrent Triple-Negative Breast Cancer [Phase 1, Phase 2]
This trial update reports Phase 1/2 results for the combination of cediranib and olaparib in recurrent ovarian, fallopian tube, or primary p…
-
CLINICAL_TRIALS trial_result · 2020-07-09Clinical Trial Update: A Study of Pembrolizumab on the Tumoral Immunoprofile of Gynecologic Cancers [EARLY_Phase 1]
Early-phase study evaluating pembrolizumab in gynecologic cancers; study completed with results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-06-09Clinical Trial Update: A Study of Mirvetuximab Soravtansine vs. Investigator's Choice of Chemotherapy in Women With Folate Receptor (FR) Alpha Positive Advanced Epithelial Ovarian Cancer (EOC), Primary Peritoneal or Fallopian Tube Cancer [Phase 3]
Phase 3 trial comparing mirvetuximab soravtansine to investigator's choice chemotherapy in FR alpha-positive advanced epithelial ovarian, pr…
-
CLINICAL_TRIALS trial_result · 2020-05-04Clinical Trial Update: Phase I/IIa Trial of Folate Binding Protein Vaccine in Ovarian Cancer [Phase 1, Phase 2]
Phase I/IIa trial update for a folate binding protein vaccine in ovarian cancer, with completed status across Phase 1 and Phase 2.
-
CLINICAL_TRIALS trial_result · 2020-04-08Clinical Trial Update: Erlotinib and Carboplatin in Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 2]
Phase 2 trial evaluating erlotinib in combination with carboplatin for recurrent ovarian, fallopian tube, or primary peritoneal cancer compl…
-
CLINICAL_TRIALS trial_result · 2020-04-06Clinical Trial Update: Lurtotecan Liposome in Treating Patients With Advanced or Recurrent Ovarian Epithelial Cancer [Phase 2]
Phase 2 clinical trial evaluating lurtotecan liposome in advanced or recurrent ovarian epithelial cancer has completed.
-
CLINICAL_TRIALS trial_result · 2020-04-02Clinical Trial Update: Combination Chemotherapy Regimens in Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer [Phase 3]
Phase 3 trial evaluating combination chemotherapy regimens for ovarian epithelial cancer, primary peritoneal cancer, and fallopian tube canc…
-
CLINICAL_TRIALS trial_result · 2020-03-25Clinical Trial Update: Japan Phase 2 Study of Niraparib (Maintenance Therapy) in Participants With Relapsed Ovarian Cancer [Phase 2]
Takeda-sponsored phase 2 trial evaluating niraparib as maintenance therapy in Japanese participants with relapsed ovarian cancer has complet…
-
CLINICAL_TRIALS trial_result · 2020-02-28Clinical Trial Update: Tivozanib in Recurrent, Platinum-Resistant Ovarian, Fallopian Tube or Primary Peritoneal Cancer [Phase 2]
Phase 2 trial update for tivozanib in recurrent platinum-resistant ovarian, fallopian tube, or primary peritoneal cancer has completed with …
-
CLINICAL_TRIALS trial_result · 2020-02-17Clinical Trial Update: Trial of Tri-weekly TJ Versus Weekly TJ for Stage II-IV Mullerian Carcinoma [Phase 3]
A Phase 3 trial comparing tri-weekly TJ to weekly TJ in stage II-IV Mullerian carcinoma (epithelial ovarian cancer and related cancers) has …
-
CLINICAL_TRIALS trial_result · 2019-12-18Clinical Trial Update: Phase 2 AMG 386 in Comb. Paclitaxel for Subjects With Advanced Recurrent Epithelial Ovarian or Primary Peritoneal Cancer [Phase 2]
Phase 2 clinical trial update evaluating AMG 386 in combination with Paclitaxel for advanced recurrent epithelial ovarian cancer and related…
-
CLINICAL_TRIALS trial_result · 2019-12-10Clinical Trial Update: Reduction Of Cycles of neOadjuvant Chemotherapy for Advanced Epithelial Ovarian, Fallopian and Primary Peritoneal Cancer [Phase 3]
Phase 3 clinical trial assessing reduction of cycles of neoadjuvant chemotherapy for advanced epithelial ovarian, fallopian tube, and primar…
-
CLINICAL_TRIALS trial_result · 2019-11-22Clinical Trial Update: Adavosertib Plus Chemotherapy in Platinum-Resistant Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 2]
Phase 2 trial evaluating adavosertib in combination with chemotherapy for platinum-resistant epithelial ovarian, fallopian tube, or primary …
-
CLINICAL_TRIALS trial_result · 2019-11-08Clinical Trial Update: A Phase 1b Study of Paclitaxel And Ricolinostat For The Treatment Of Gynecological Cancer [Phase 1]
Phase 1b study of paclitaxel with ricolinostat for gynecologic cancer was terminated; results posted.
-
CLINICAL_TRIALS trial_result · 2019-11-06Clinical Trial Update: Efficacy of HIPEC in the Treatment of Advanced-Stage Epithelial Ovarian Cancer After Cytoreductive Surgery [Phase 3]
A Phase 3 clinical trial evaluating the efficacy of HIPEC following cytoreductive surgery for advanced epithelial ovarian cancer (including …